Evidence-Based Medicine Guidelines
Early versus deferred treatment for early stage multiple myeloma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Early Versus Deferred Treatment for Early Stage Multiple Myeloma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455008/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma.
Early versus deferred treatment for early stage multiple myeloma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455008/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma. Accessed November 28, 2023.
Early versus deferred treatment for early stage multiple myeloma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455008/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma
Early Versus Deferred Treatment for Early Stage Multiple Myeloma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455008/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Early versus deferred treatment for early stage multiple myeloma
ID - 455008
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455008/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
